LibiGel FDA Approval Status
FDA Approved: No
Brand name: LibiGel
Generic name: testosterone
Dosage form: Gel
Company: Antares Pharma, Inc. and BioSante Pharmaceuticals Inc.
Treatment for: Hypoactive Sexual Desire Disorder
LibiGel (testosterone) is a transdermal gel formulation of testosterone in development for the treatment of hypoactive sexual desire disorder.
Development timeline for LibiGel
|Jun 21, 2010||BioSante Pharmaceuticals Says FDA Advisory Committee Recommendation Against Flibanserin has No Impact on LibiGel|
|Oct 2, 2007||Antares Reports Product Progress in Growing Women's Health Portfolio|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.